Login
Get Started
Today
Browse
Screens
Folios
Discuss
Learn
Browse
Shares
Healthcare
Biotechnology & Medical Research
Inflarx NV
IFRX -
Inflarx NV
Share News
$4.29
-0.0 -0.5%
Last Trade -
02/03/21
Sector
Healthcare
RiskRating
Speculative
Size
Small Cap
Style
Sucker Stock
Market Cap
£133.8m
Enterprise Value
£51.9m
Revenue
£n/a
Position in Universe
4494th / 6633
Quality
Value
Momentum
Stock
Rank™
StockReport™
Tools
Compare with...
Run through checklist
Accounts
Balance sheet
Income statement
Cashflow statement
Dividend summary
Charts
News
Discussions
IFRX Dividends
All News
All News
Reuters News
Company Announcements
InflaRx Announces Closing of $75 Million Public Offering of Common Shares and One-Year Warrants
Mon 9:01pm
News
BRIEF-Inflarx Announces Pricing Of $75 Million Public Offering Of Common Shares And One-Year Warrants
Thu 2:39pm
News
InflaRx Announces Pricing of $75 Million Public Offering of Common Shares and One-Year Warrants
Thu 1:30pm
News
BRIEF-InflaRx Reports Proposed Offering of Common Shares and One-Year Warrants
24th Feb
News
InflaRx Announces Proposed Offering of Common Shares and One-Year Warrants
24th Feb
News
InflaRx Announces Presentation of New C5a and Vilobelimab (IFX-1) Data from Phase IIB SHINE Study at the 2021 Virtual European Hidradenitis Suppurativa Foundation Conference
11th Feb
News
BRIEF-Inflarx NV Says Phase II Trial In Patients With Cutaneous Squamous Cell Carcinoma To Start In First Half 2021
11th Jan
News
InflaRx Provides Update on Vilobelimab (IFX-1) Development
11th Jan
News
InflaRx to Present at Upcoming Annual J.P. Morgan Healthcare Conference
7th Jan
News
BRIEF-Inflarx Completes Enrollment In Vilobelimab (Ifx-1) European Phase Ii Study In Anca-Associated Vasculitis
5th Jan
News
InflaRx Completes Enrollment in Vilobelimab (IFX-1) European Phase II Study in ANCA-associated Vasculitis
5th Jan
News
BRIEF-Inflarx Reports Q3 Loss Per Share EUR 0.25
29th Oct '20
News
InflaRx Reports Q3 2020 Financial & Operating Results
29th Oct '20
News
BRIEF-InflaRx NV Says Thomas Taapken Appointed CFO
17th Sep '20
News
InflaRx Announces Leadership Team Additions with New CFO and Newly Created Position of Chief Strategy Officer
17th Sep '20
News
BUZZ-InflaRx NV: Jumps on starting late-stage trial of potential COVID-19 treatment
14th Sep '20
News
BRIEF-InflaRx Announces Start Of Phase III Part Of Phase II/III Clinical Trial With IFX-1 In COVID-19-Induced Pneumonia
14th Sep '20
News
InflaRx Announces Initiation of Phase III Part of Phase II/III Clinical Trial with IFX-1 in Severe COVID-19 Induced Pneumonia
14th Sep '20
News
InflaRx to Present at Upcoming Virtual Investor Events
6th Aug '20
News
BRIEF-Inflarx Reports Qtrly Loss Per Share Eur 0.38
30th Jul '20
News
1
2
Next »
Unlock the metrics for all these stocks and more...
Unlock
with Google
Unlock with Facebook
Unlock with Email
Unlock
with Google
Unlock
with Facebook
or
Unlock with your email
© Stockopedia 2021, Refinitiv, Share Data Services.
Facebook
Twitter
Youtube
Instagram
RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our
Terms of Use
,
Privacy
and
Disclaimer
policies.
Unlock the metrics for all these stocks and more...
Unlock
with Google
Unlock with Facebook
Unlock with Email
Unlock
with Google
Unlock
with Facebook
or
Unlock with your email